India cracks down on misuse of weight-loss drugs across supply chain
In response to the rise of generic GLP-1 weight-loss drugs in India, the drug regulator is stepping up audits and enforcement actions against unauthorized sales and improper prescriptions, ensuring patient safety as the market expands amid an obesity crisis.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
